Haddadin Yezan Munther (CIK 1718004) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Buy OTLK (29,000 shares), Buy OTLK (34,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 29,000 | $24,145 |
| 2026-05-27 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 34,000 | $14,960 |
Source: SEC Form 4 filings · as of 2026-06-03